首页> 美国卫生研究院文献>Prostate International >Efficacy and safety of cabazitaxel therapy in elderly (≥75 years) patients with castration-resistant prostate cancer: A multiinstitutional study

【2h】

Efficacy and safety of cabazitaxel therapy in elderly (≥75 years) patients with castration-resistant prostate cancer: A multiinstitutional study

机译：Cabazitaxel治疗在老年人（≥75岁）抗阉割前列腺癌患者中的疗效和安全性：多合式研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

There is little data on the outcome of cabazitaxel (CBZ) treatment of elderly patients with castration-resistant prostate cancer (CRPC). This study assessed the efficacy and safety of CBZ chemotherapy in patients with CRPC aged 75 years or older in a multiinstitutional study.

机译：有关Cabazitaxel（CBZ）治疗抗阉割前列腺癌（CRPC）的患者的疗效几乎没有数据。本研究评估了CBZ化疗在多种机构研究中为75岁或以上的CRPC患者的疗效和安全性。

著录项

期刊名称 Prostate International
作者
Takashi Matsumoto; Masaki Shiota; Motonobu Nakamura; Akira Yokomizo; Toshihisa Tomoda; Naotaka Sakamoto; Narihito Seki; Shuji Hasegawa; Takakazu Yunoki; Masahiko Harano; Kentaro Kuroiwa; Masatoshi Eto;
展开▼
作者单位

展开▼
年(卷),期 2021(9),2
年度 2021
页码 96–100
总页数 5
原文格式 PDF
正文语种
中图分类
关键词

机译：Cabazitaxel;抵抗阉割前列腺癌;疗效;安全;老人;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of cabazitaxel therapy in elderly (≥75?years) patients with castration-resistant prostate cancer: A multiinstitutional study [J] . Takashi Matsumoto, Masaki Shiota, Motonobu Nakamura, Prostate International . 2021,第2期

机译：Cabazitaxel治疗在老年人（≥75岁）患者抗阉割前列腺癌患者的疗效和安全性：多合式机构研究
2. Efficacy and safety of cabazitaxel for castration-resistant prostate cancer in patients with 10 cycles of docetaxel chemotherapy: a multi-institutional study [J] . Shiota Masaki, Nakamura Motonobu, Yokomizo Akira, Medical oncology . 2019,第4期

机译：Cabazitaxel对抗阉割前列腺癌的Cabazitaxel的疗效和安全性; 10个循环的多西紫杉醇化疗：多制度研究
3. Re: Efficacy and Safety of Abiraterone Acetate in an Elderly Patient Subgroup (Aged 75 and Older) with Metastatic Castration-Resistant Prostate Cancer after Docetaxel-Based Chemotherapy [J] . Griebling Tomas L. The Journal of Urology . 2015,第2期

机译：回复：醋酸阿比特龙在多西他赛为基础的化学疗法后对转移性去势抵抗性前列腺癌的老年患者亚组（75岁及以上）的疗效和安全性
4. Sequencing of Therapies in Men with Castration-Resistant Prostate Cancer [C] . Philip Kantoff Genitourinary Cancers Symposium . 2012

机译：抗阉割前列腺癌的男性疗法测序
5. Muscle Cross-Sectional Area Is Improved and Physical Funciton Is Maintained After Home-Based Exercise in Men with Metastatic Castration-Resistant Prostate Cancer Undergoing Androgen Deprivation Therapy [D] . Alzer, Mohamdod Saber. 2020

机译：改善肌横截面积，并且在具有转移阉割的前列腺癌接受雄激素剥夺治疗的男性中的男性锻炼之后，将物理静脉凝集维持
6. Efficacy and Safety of Abiraterone Acetate in Elderly (≥75 Years) Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer [O] . Matthew R. Smith, Dana E. Rathkopf, Peter. F.A. Mulders, -1

机译：醋酸阿比特龙在年龄≥75岁的未接受化疗的转移性去势抵抗性前列腺癌患者中的疗效和安全性
7. Safety and efficacy of cabazitaxel in Japanese patients with castration-resistant prostate cancer [O] . Teppei Yamamoto, Osamu Ishizuka, Hiroshi Oike, 2020

机译：Cabazitaxel在日本阉割前列腺癌患者中的安全性和有效性

Efficacy and safety of cabazitaxel therapy in elderly (≥75 years) patients with castration-resistant prostate cancer: A multiinstitutional study

摘要

著录项

相似文献

相关主题

期刊订阅